Evidence map›Paper›PMID 42006869›Full record

ArticleFrontiers in medicine2026

Clinical features and prognostic factors of

Yanyan Li, Hongyi Zhu, Zijie Zhan, Ge Li, Quan Zhou, Chao Zheng, Fan Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yanyan LiDepartment of Respiratory and Critical Diseases, The Affiliated Changde Hospital of Xiangya School of Medicine, Central South University, Changde, Hunan, China.
Hongyi ZhuDepartment of Science and Education Section, The Affiliated Changde Hospital of Xiangya School of Medicine, Central South University, Changde, Hunan, China.
Zijie ZhanDepartment of Radiology, The Affiliated Changde Hospital of Xiangya School of Medicine, Central South University, Changde, Hunan, China.
Ge LiDepartment of Quality Control Department, The Affiliated Changde Hospital of Xiangya School of Medicine, Central South University, Changde, Hunan, China.
Quan ZhouDepartment of Science and Education Section, The Affiliated Changde Hospital of Xiangya School of Medicine, Central South University, Changde, Hunan, China.
Chao ZhengDepartment of Radiology, The Affiliated Changde Hospital of Xiangya School of Medicine, Central South University, Changde, Hunan, China.
Fan HuangDepartment of Radiology, The Affiliated Changde Hospital of Xiangya School of Medicine, Central South University, Changde, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: This retrospective study analyzed 74 patients diagnosed with CPP via metagenomic (mNGS) and targeted next-generation sequencing (tNGS) between January 2022 and September 2025. Patients were categorized into severe ( Results: The cohort had a median age of 60 years, with a male predominance (62.2%). A history of poultry/bird exposure was reported by 87.8% of participants. Common symptoms included fever (94.6%), cough (63.5%), and fatigue (29.7%), with no significant differences between groups. Hospitalization was significantly longer in the severe group (12.95 ± 6.08 days) than in the non-severe group (8.13 ± 3.30 days) ( Conclusion: Severe CPP is associated with prolonged hospitalization, bilateral pulmonary infiltrates, and pleural effusion. D-dimer and lymphocyte percentage are valuable prognostic indicators for disease severity. Early targeted antibiotic therapy is effective, but timely respiratory support is critical for severe cases.

Indexed as

Chlamydia psittaciclinical featuresnext-generation sequencing (NGS)prognosispsittacosis pneumonia

Identifiers

PMID42006869
PMCPMC13083060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.